Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies

Simple Summary Oral potentially malignant disorders (OPMDs) include a group of oral mucosal diseases with different morphological characteristics that are able to progress to oral squamous cell carcinoma (OSCC). Given OSCC’s poor prognosis and high mortality, early diagnosis is a priority step in OSCC. Extrinsic and intrinsic risk factors and etiologies are involved in developing and malignant transformation of oral lesions, and different molecular alterations have been described in early lesions associated with a potential malignant behavior. This review summarizes the information about clinical, morphological and molecular features of OPMDs, with an emphasis on the early detection techniques and an overview of the surgical and systemic therapies’ effectiveness. Abstract Oral squamous cell carcinoma (OSCC) is a very aggressive cancer, representing one of the most common malignancies worldwide. Oral potentially malignant disorders (OPMDs) regroup a variegate set of different histological lesions, characterized by the potential capacity to transform in OSCC. Most of the risk factors associated with OSCC are present also in OPMDs’ development; however, the molecular mechanisms and steps of malignant transformation are still unknown. Treatment of OSCC, including surgery, systemic therapy and radiotherapy (alone or in combination), has suffered a dramatic change in last years, especially with the introduction of immunotherapy. However, most cases are diagnosed during the advanced stage of the disease, decreasing drastically the survival rate of the patients. Hence, early diagnosis of premalignant conditions (OPMDs) is a priority in oral cancer, as well as a massive education about risk factors, the understanding of mechanisms involved in malignant progression and the development of specific and more efficient therapies. The aim of this article is to review epidemiological, clinical, morphological and molecular features of OPMDs, with the purpose to lay the foundation for an exhaustive comprehension of these lesions and their ability of malignant transformation and for the development of more effective and personalized treatments.

[1]  H. Holmes,et al.  Treatment of oral fungal infections using photodynamic therapy: Systematic review and meta‐analysis , 2021, Clinical and experimental dental research.

[2]  S. Warnakulasuriya,et al.  Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years. , 2021, Oral diseases.

[3]  M. D’Incalci,et al.  Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma , 2021, Theranostics.

[4]  S. Warnakulasuriya,et al.  Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed with Oral Leukoplakia. A Systematic Review. , 2020, Oral diseases.

[5]  S. Bondi,et al.  Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis , 2020, International journal of environmental research and public health.

[6]  Tzong-Ming Shieh,et al.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments , 2020, International journal of molecular sciences.

[7]  S. Rogatto,et al.  The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis. , 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[8]  G. Madhushankari,et al.  Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review. , 2020, Journal of oral biology and craniofacial research.

[9]  S. Kvaal,et al.  Photodynamic therapy of oral lichen planus , 2020, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  M. Grootveld,et al.  Laser-Assisted aPDT Protocols in Randomized Controlled Clinical Trials in Dentistry: A Systematic Review , 2020, Dentistry journal.

[11]  L. De Cecco,et al.  Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions , 2020, Cells.

[12]  Yuan He,et al.  Oral microbiota alteration associated with oral cancer and areca chewing. , 2020, Oral diseases.

[13]  M. Magalhaes,et al.  Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study , 2020, Scientific Reports.

[14]  S. Kjaer,et al.  Human papillomavirus prevalence in oral potentially malignant disorders: systematic review and meta-analysis. , 2020, Oral diseases.

[15]  L. Gudas,et al.  Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma. , 2020, Carcinogenesis.

[16]  P. Speight,et al.  Human papillomavirus (HPV) can establish productive infection in dysplastic oral mucosa, but HPV status is poorly predicted by histological features and p16 expression , 2020, Histopathology.

[17]  S. Papadiochou,et al.  Medical practitioners' educational competence about oral and oropharyngeal carcinoma: a systematic review and meta-analysis. , 2019, The British journal of oral & maxillofacial surgery.

[18]  Ze Lu,et al.  Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells , 2019, DNA and cell biology.

[19]  Hung-Ming Wang,et al.  Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study , 2019, The Lancet.

[20]  Li‐yu Lee,et al.  Multifaceted Mechanisms of Areca Nuts in Oral Carcinogenesis: the Molecular Pathology from Precancerous Condition to Malignant Transformation , 2019, Journal of Cancer.

[21]  P. Pandolfi,et al.  miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells , 2019, Journal of experimental & clinical cancer research : CR.

[22]  Bing-jie Wang,et al.  Photodynamic therapy in the treatment of oral leukoplakia: A systematic review. , 2019, Photodiagnosis and photodynamic therapy.

[23]  R. Milewski,et al.  A clinical evaluation of efficacy of photodynamic therapy in treatment of reticular oral lichen planus: A case series. , 2019, Photodiagnosis and photodynamic therapy.

[24]  L. Alemany,et al.  Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort , 2019, PloS one.

[25]  O. V. Matorin,et al.  Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study , 2019, The Lancet.

[26]  M. Verma,et al.  Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer , 2019, Technology in cancer research & treatment.

[27]  F. Carinci,et al.  The Effectiveness of Laser-Assisted Surgical Excision of Leukoplakias and Hyperkeratosis of Oral Mucosa: A Case Series in A Group of Patients , 2019, International journal of environmental research and public health.

[28]  S. Lippman,et al.  Immunological and classical subtypes of oral premalignant lesions , 2018, Oncoimmunology.

[29]  L. V. Muniz,et al.  Reduced CD8+ T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions , 2018, Clinical Oral Investigations.

[30]  S. Arora,et al.  Areca nut trade, globalisation and its health impact: perspectives from India and South-east Asia , 2018, Perspectives in public health.

[31]  D. Kademani,et al.  Management update of potentially premalignant oral epithelial lesions. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[32]  S. Warnakulasuriya.  Clinical features and presentation of oral potentially malignant disorders. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[33]  S. Porter,et al.  Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[34]  S. Müller.  Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[35]  M. Sperandio,et al.  Meta‐analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  B. Takkouche,et al.  The length of patient and primary care time interval in the pathways to treatment in symptomatic oral cancer. A quantitative systematic review , 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[37]  D. Saranath,et al.  High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications , 2017, Oncology.

[38]  Xun Chen,et al.  Human papillomavirus infection in oral potentially malignant disorders and cancer. , 2017, Archives of oral biology.

[39]  M. García-Pola,et al.  Treatment of oral lichen planus. Systematic review and therapeutic guide. , 2017, Medicina clinica.

[40]  S. Bicciato,et al.  Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence , 2017, Modern Pathology.

[41]  M. Popovska,et al.  Human Papillomavirus as a Potential Risk Factor for Oral Premalignant Lesions. , 2017, Acta clinica Croatica.

[42]  N. Lindeman,et al.  HPV-16 in a distinct subset of oral epithelial dysplasia , 2017, Modern Pathology.

[43]  T. Sollecito,et al.  Oral lesions associated with Fanconi anemia , 2017, Revista brasileira de hematologia e hemoterapia.

[44]  M. Goodman,et al.  Betel nut chewing, oral premalignant lesions, and the oral microbiome , 2017, PloS one.

[45]  S. Rai,et al.  Histologic variation in high grade oral epithelial dysplasia when associated with high-risk human papillomavirus. , 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

[46]  L. Grando,et al.  Proliferative verrucous leukoplakia: diagnosis, management and current advances , 2017, Brazilian journal of otorhinolaryngology.

[47]  J. Radford.  Nivolumab for recurrent squamous-cell carcinoma of the head and neck , 2016, BDJ.

[48]  M. Young,et al.  Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer , 2016, Front. Immunol..

[49]  Z. Kurago.  Etiology and pathogenesis of oral lichen planus: an overview. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[50]  N. Cirillo,et al.  Oral lichen planus: a literature review and update , 2016, Archives of Dermatological Research.

[51]  Li‐yu Lee,et al.  Areca nut contributes to oral malignancy through facilitating the conversion of cancer stem cells , 2016, Molecular carcinogenesis.

[52]  E. Chimenos-Küstner,et al.  Oral leukoplakia treatment with the carbon dioxide laser: A systematic review of the literature. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[53]  B. Takkouche,et al.  Early oral cancer diagnosis: The Aarhus statement perspective. A systematic review and meta‐analysis , 2016, Head & neck.

[54]  Edward S. Kim,et al.  Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. , 2016, JAMA oncology.

[55]  S. Warnakulasuriya,et al.  An appraisal of oral cancer and pre-cancer screening programmes in Europe: a systematic review. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[56]  R. Annigeri,et al.  Role of oxidative stress in the pathogenesis of oral submucous fibrosis: A preliminary prospective study , 2015, Contemporary clinical dentistry.

[57]  E. Chimenos-Küstner,et al.  The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients. , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[58]  G. Ogden,et al.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. , 2015, The Cochrane database of systematic reviews.

[59]  M. B. Gillespie,et al.  Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta‐analysis , 2015, Head & neck.

[60]  T. Qadri,et al.  Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review. , 2015, Photodiagnosis and photodynamic therapy.

[61]  M. Grimm,et al.  Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC , 2015, Medicina oral, patologia oral y cirugia bucal.

[62]  Y. Lee,et al.  Outcome of excision of oral erythroplakia. , 2015, The British journal of oral & maxillofacial surgery.

[63]  P. Strojan,et al.  Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention". , 2015, Oral oncology.

[64]  David R. Riley,et al.  Notch1 Mutations Are Drivers of Oral Tumorigenesis , 2014, Cancer Prevention Research.

[65]  Dineshkumar Thayalan,et al.  Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[66]  J. Teruya-Feldstein,et al.  The diagnosis and treatment of dyskeratosis congenita: a review , 2014, Journal of blood medicine.

[67]  M. Young,et al.  Effect of the Premalignant and Tumor Microenvironment on Immune Cell Cytokine Production in Head and Neck Cancer , 2014, Cancers.

[68]  Sumit Goel,et al.  Clinical correlative study on early detection of oral cancer and precancerous lesions by modified oral brush biopsy and cytology followed by histopathology. , 2014, Journal of cancer research and therapeutics.

[69]  A. Guimarães,et al.  Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[70]  Crispian Scully,et al.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. , 2013, The Cochrane database of systematic reviews.

[71]  Simon Shepherd,et al.  Screening programmes for the early detection and prevention of oral cancer. , 2013, The Cochrane database of systematic reviews.

[72]  P. Brennan,et al.  Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management. , 2013, The British journal of oral & maxillofacial surgery.

[73]  P. Saintigny,et al.  Oral premalignancy: the roles of early detection and chemoprevention. , 2013, Otolaryngologic clinics of North America.

[74]  D. Sugiyama,et al.  Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. , 2013, Arthritis and rheumatism.

[75]  L. Wirth,et al.  Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial , 2013, Cancer Prevention Research.

[76]  B. Perez-Ordonez,et al.  Association of high-risk human papillomavirus infection with oral epithelial dysplasia. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[77]  S. Kometa,et al.  Complications following interventional laser surgery for oral cancer and precancerous lesions. , 2012, The British journal of oral & maxillofacial surgery.

[78]  J. J. Lee,et al.  Loss of Heterozygosity (LOH) Profiles—Validated Risk Predictors for Progression to Oral Cancer , 2012, Cancer Prevention Research.

[79]  S. Warnakulasuriya,et al.  Oral lichenoid contact lesions induced by areca nut and betel quid chewing: a mini review. , 2012, Journal of investigative and clinical dentistry.

[80]  H. Sudhoff,et al.  Oral sex, cancer and death: sexually transmitted cancers , 2012, Head & neck oncology.

[81]  A. Petrie,et al.  The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication , 2012, Head & neck oncology.

[82]  L. See,et al.  Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan , 2012, Scandinavian journal of rheumatology.

[83]  L. D. de Souza,et al.  Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system. , 2011, Oncology letters.

[84]  N. Stasche,et al.  S2k-Leitlinie: Diagnostik und Management von Vorläuferläsionen des oralen Plattenepithelkarzinoms in der Zahn-, Mund- und Kieferheilkunde , 2011 .

[85]  R. G. Resende,et al.  Oral leukoplakia in a patient with Fanconi anemia: recurrence or a new primary lesion? , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[86]  M. Gonzalez-Moles,et al.  Methylation in oral cancer and pre-cancerous lesions (Review). , 2011, Oncology reports.

[87]  P. Angadi,et al.  Areca nut in pathogenesis of oral submucous fibrosis: revisited , 2011, Oral and Maxillofacial Surgery.

[88]  H. Sørensen,et al.  Systemic sclerosis and the risk of cancer: a nationwide population‐based cohort study , 2010, The British journal of dermatology.

[89]  Edward S. Kim,et al.  Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer , 2010, Cancer Prevention Research.

[90]  I. Waal.  Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management , 2010 .

[91]  Igor Jurisica,et al.  Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. , 2009, Human molecular genetics.

[92]  S. Warnakulasuriya,et al.  Nomenclature and classification of potentially malignant disorders of the oral mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[93]  J. Califano,et al.  Molecular genetics of premalignant oral lesions. , 2007, Oral diseases.

[94]  T. Axéll,et al.  Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[95]  T. Peters,et al.  Effect of areca nut on salivary copper concentration in chronic chewers , 2007, BioMetals.

[96]  Philip Sloan,et al.  Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. , 2006, Oral oncology.

[97]  E. Sausville,et al.  Persistent Activation of the Akt Pathway in Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[98]  C. Rudin,et al.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  C. Ostwald,et al.  Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions , 2003, Medical Microbiology and Immunology.

[100]  T. Sollecito,et al.  Betel quid-induced oral lichen planus: a case report. , 2003, Cutis.

[101]  J. Epstein,et al.  The effect of retinoids on premalignant oral lesions , 2002, Cancer.

[102]  B. Casto,et al.  Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. , 2002, Cancer research.

[103]  T. Peters,et al.  Areca nut use: an independent risk factor for oral cancer , 2002, BMJ : British Medical Journal.

[104]  S. Warnakulasuriya,et al.  Chemical and analytical aspects of areca nut , 2002, Addiction biology.

[105]  S. Warnakulasuriya,et al.  Global epidemiology of areca nut usage , 2002, Addiction biology.

[106]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[107]  S. Lippman,et al.  Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. , 1998, Journal of the National Cancer Institute.

[108]  T. Peters,et al.  Copper content in Areca catechu (betel nut) products and oral submucous fibrosis , 1997, The Lancet.

[109]  S. Lippman,et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.

[110]  D. Zegarelli.  TREATMENT OF ORAL LICHEN PLANUS , 1990, The Lancet.

[111]  N. Gale,et al.  Precursor Lesions for Squamous Carcinoma in the Upper Aerodigestive Tract , 2021 .

[112]  Priyanka Gubrellay,et al.  Assessment and correlation between functional and histological staging of oral submucous fibrosis: A clinicohistopathologic study , 2019, National journal of maxillofacial surgery.

[113]  L. Laino,et al.  Systemic and topical photodynamic therapy (PDT) on oral mucosa lesions: an overview. , 2018, Journal of biological regulators and homeostatic agents.

[114]  C. McConkey,et al.  The binary oral dysplasia grading system: validity testing and suggested improvement. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[115]  I. van der Waal,et al.  Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. , 2009, Oral oncology.